Sustiva LogoHome Your Sustiva Your HIV Treatment Managing Side Effects Tools & Resources
Patient Information
Full Prescribing Information
* Undetectable is defined as a viral load of less than 400 copies/mL or less than 50 copies/mL (depending on the test used).
Up to 168 weeks.

Find out more about SUSTIVA as part of your HIV combination therapy

You want to know more about your HIV medicine—and we want to help. This site may help answer your questions
about SUSTIVA—and assist you in working with your doctor to better understand your HIV treatment.

SUSTIVA is a prescription medicine used in combination with other medicines to treat people who are infected with
the human immunodeficiency virus type 1 (HIV-1). In HIV combination therapy, SUSTIVA can help keep viral loads
undetectable* for a long time and has been shown to help improve your body’s immune system by raising your
CD4+ cell (T-cell) count. SUSTIVA does not cure HIV and has not been shown to prevent passing HIV to others.

Learn more about your Sustiva Medication

REFERENCES 1. AIDSinfo. Glossary. Department of Health and Human Services. June 19, 2009. Available at
http://aidsinfo.nih.gov/Glossary/GlossaryDefaultCenterPage.aspx. Accessed July 8, 2009.
IMPORTANT INFORMATION ABOUT SUSTIVA® (efavirenz)

INDICATION:
SUSTIVA® (efavirenz) is a prescription medicine used in combination with other medicines to treat people who are infected with the human immunodeficiency virus type 1 (HIV-1).

SUSTIVA does not cure HIV and has not been shown to prevent passing HIV to others.

See your healthcare provider regularly.

IMPORTANT SAFETY INFORMATION:
Do not take SUSTIVA if you are taking the following medicines because serious and life-threatening side effects may occur when taken together:
Vascor® (bepridil),
Propulsid® (cisapride),
Versed® (midazolam), Orap® (pimozide), Halcion® (triazolam), or ergot medicines (for example,Wigraine® and Cafergot®).

Taking SUSTIVA with St. John’s wort (Hypericum perforatum) is not recommended, as it may cause decreased levels of SUSTIVA, increased viral load, and possible resistance to SUSTIVA or cross-resistance to other anti-HIV drugs.

SUSTIVA should not be taken with ATRIPLA® (efavirenz 600 mg / emtricitabine 200 mg/tenofovir    disoproxil fumarate 300mg) because it contains efavirenz, the active ingredient in SUSTIVA.

If you are taking SUSTIVA with
REYATAZ® (atazanavir sulfate), your REYATAZ may need to be replaced if this is not the first time you are receiving treatment for your HIV infection. Other drugs that may also need to be replaced include
Fortovase® (saquinavir),
Invirase® (saquinavir),
Biaxin® (clarithromycin),
Carbatrol® (carbamazepine),
Tegretol® (carbamazepine),
Noxafil® (posaconazole) and
Sporonox® (itraconazole).

SUSTIVA and Vfend® (voriconazole)
must not be taken together at standard doses. Some doses of voriconazole can be taken at the same time as a lower dose of SUSTIVA, but you must check with your healthcare provider first.

These are not all the medicines that may cause problems if you take SUSTIVA® (efavirenz). Discuss with your healthcare provider all prescription and nonprescription medicines, vitamins, and herbal supplements you are taking or plan to take.

Tell your healthcare provider right away if you have any side effects or conditions, including the following:

  • Severe depression, strange thoughts, or angry behavior have been reported by a small number of patients taking SUSTIVA. Some patients have had thoughts of suicide and a few have actually committed suicide. These problems may occur more often in patients who have had mental illness.

  • Dizziness, trouble sleeping or concentrating, drowsiness, and/or unusual dreams, are
    common, and tend to go away after taking SUSTIVA for a few weeks. Symptoms were severe in a few patients, and some patients discontinued therapy. These symptoms may become more severe with the use of alcohol and/or mood-altering (street) drugs. If you are dizzy, have trouble concentrating, and/or are drowsy, avoid activities that may be dangerous, such as driving or operating machinery.

  • If you have ever had mental illness or are using drugs or alcohol.

  • Pregnancy: Women should not become pregnant while taking SUSTIVA® (efavirenz) and for 12 weeks after stopping SUSTIVA. Serious birth defects have been seen in children of women treated with SUSTIVA during pregnancy. Therefore, women must use a reliable form of barrier contraception, such as a condom or diaphragm, even if they also use other methods of birth control.

  • Breast-feeding: Women with HIV should not breast-feed because they can pass HIV through their milk to the baby. Also, SUSTIVA may pass through breast milk and cause serious harm to the baby.

  • Rash is a common side effect that usually goes away without any change in your medicines, but may be serious in a small number of patients. Rash may be a serious problem in some children.

  • Liver problems: Some patients taking SUSTIVA have experienced serious liver problems including liver failure resulting in transplantation or death. Most of these serious side effects occurred in patients with a chronic liver disease such as hepatitis infection, but there have also been reports in patients without any existing liver disease. Your healthcare provider may want to do tests to check your liver.

  • Seizures have occurred in patients taking SUSTIVA, usually in those with a history of seizures. If you have ever had seizures or take medicines for seizures, your healthcare provider may want to switch you to another medicine or monitor you.

Changes in body fat have been seen in some patients taking anti-HIV medicines. The cause and long-term health effects are not known.

Other common side effects of SUSTIVA® (efavirenz) taken with other anti-HIV medicines include: tiredness, upset stomach, vomiting, and diarrhea. Some patients taking SUSTIVA have experienced increased levels of lipids (cholesterol and triglycerides) in the blood.

You should take SUSTIVA on
an empty stomach, preferably at bedtime, which may make some side effects less bothersome.

Full Prescribing Information

CD4+ cell: A type of white blood cell that fights infection and can be attacked by HIV (sometimes called a T-cell).1
Viral load: How much virus is in a sample of your blood; usually measured as the number of copies of virus per milliliter of blood. It may be used to judge how well your treatment is working.1
Drug resistance: Antiretroviral medicines work by helping to slow replication of the virus.1 When HIV becomes resistant to a medicine, this means that the virus has mutated (or changed form) and its replication can no longer be controlled by that medicine.1